Oct 6 (Reuters) - Amgen said on Friday it had completed the acquisition of Horizon Therapeutics after it received the go-ahead last month from the U.S. Federal Trade Commission. The companies said in September they expected the deal to close early in the fourth quarter. (Reporting by Mariam Sunny in Bengaluru; Editing by Anil D'Silva)